Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 26.45x is 32% below its estimated 3-year average of 39.08x, near the low end of its estimated 3-year range (11.23x–268.97x).
As of 2026-10-06T18:32:17.786Z. 19.04% below its estimated 12-month average of 32.67x.
Calculation as of: 2026-10-06T18:32:17.786Z.
Quote observation: 2026-10-06T18:30:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7123ab057bb1841ee835f9c71551e031ef341e3ba9317ad50f2164e9d5c136ac
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
26.45x
EV/FCF RATIO AVG TTM
32.67x
EV/FCF RATIO AVG 3Y
37.53x
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-19.04%
CURRENT VS 3Y AVG
-29.52%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
24.98x
median of 205 covered companies
CURRENT VS SECTOR MEDIAN
+5.88%
vs the sector median at left
Niagen Bioscience Inc
Market Cap
$214.51M
EV/FCF Ratio
26.45x
TTM Avg
32.67x
3Y Avg
37.53x
5Y Avg
N/A
Market Cap
$218.58M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$215.21M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$209.97M
EV/FCF Ratio
N/A
TTM Avg
3.80x
3Y Avg
3.80x
5Y Avg
3.80x
Market Cap
$222.46M
EV/FCF Ratio
N/A
TTM Avg
0.76x
3Y Avg
0.76x
5Y Avg
0.76x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niagen Bioscience Inc (NAGE) | $214.51M | 26.45x | 32.67x | 37.53x | N/A |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $218.58M | N/A | N/A | N/A | N/A |
| Prelude Therapeutics Incorporated (PRLD)vs › | $215.21M | N/A | N/A | N/A | N/A |
| Lyell Immunopharma, Inc. (LYEL)vs › | $213.94M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $211.80M | N/A | N/A | N/A | N/A |
| Entrada Therapeutics, Inc. (TRDA)vs › | $209.97M | N/A | 3.80x | 3.80x | 3.80x |
| Keros Therapeutics, Inc. (KROS)vs › | $222.46M | N/A | 0.76x | 0.76x | 0.76x |
| Pro-Dex, Inc. (PDEX)vs › | $207.93M | 31.61x | 29.35x | 31.54x | 30.56x |
| Profound Medical Corp. (PROF)vs › | $222.69M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $207.67M | N/A | N/A | N/A | N/A |
EV/FCF
26.4x
P/FCF
37.8x
FCF Yield
2.65%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-10-05 | 27.62x |
| 2026-10-02 | 29.22x |
| 2026-10-01 | 27.62x |
| 2026-09-30 | 31.11x |
| 2026-09-29 | 31.54x |
| 2026-09-28 | 31.98x |
| 2026-09-25 | 33.00x |
| 2026-09-24 | 32.42x |
| 2026-09-23 | 32.27x |
| 2026-09-22 | 33.58x |
| 2026-09-21 | 32.85x |
| 2026-09-18 | 32.12x |
| 2026-09-17 | 32.12x |
| 2026-09-16 | 32.27x |
| 2026-09-15 | 32.27x |
| 2026-09-14 | 32.85x |
| 2026-09-11 | 32.85x |
| 2026-09-10 | 32.85x |
| 2026-09-09 | 33.00x |
| 2026-09-08 | 33.72x |
| 2026-09-04 | 34.74x |
| 2026-09-03 | 33.87x |
| 2026-09-02 | 34.74x |
| 2026-09-01 | 34.16x |
| 2026-08-31 | 34.16x |
| 2026-08-28 | 36.49x |
| 2026-08-27 | 35.32x |
| 2026-08-26 | 36.63x |
| 2026-08-25 | 36.20x |
| 2026-08-24 | 35.32x |
| 2026-08-21 | 35.32x |
| 2026-08-20 | 34.45x |
| 2026-08-19 | 34.74x |
| 2026-08-18 | 33.14x |
| 2026-08-17 | 32.85x |
| 2026-08-14 | 32.56x |
| 2026-08-13 | 33.00x |
| 2026-08-12 | 33.14x |
| 2026-08-11 | 33.43x |
| 2026-08-10 | 33.00x |
| 2026-08-07 | 34.02x |
| 2026-08-06 | 32.85x |
| 2026-08-05 | 31.69x |
| 2026-08-04 | 39.10x |
| 2026-08-03 | 39.98x |
| 2026-07-31 | 38.09x |
| 2026-07-30 | 36.92x |
| 2026-07-29 | 35.47x |
| 2026-07-28 | 36.49x |
| 2026-07-27 | 35.61x |
| 2026-07-24 | 35.32x |
| 2026-07-23 | 35.03x |
| 2026-07-22 | 38.09x |
| 2026-07-21 | 39.40x |
| 2026-07-20 | 37.65x |
| 2026-07-17 | 36.34x |
| 2026-07-16 | 38.09x |
| 2026-07-15 | 39.10x |
| 2026-07-14 | 36.49x |
| 2026-07-13 | 39.10x |
| 2026-07-10 | 37.94x |
| 2026-07-09 | 39.40x |
| 2026-07-08 | 37.65x |
| 2026-07-07 | 38.81x |
| 2026-07-06 | 39.54x |
| 2026-07-02 | 38.52x |
| 2026-07-01 | 37.07x |
| 2026-06-30 | 50.12x |
| 2026-06-29 | 52.39x |
| 2026-06-26 | 54.86x |
| 2026-06-25 | 52.59x |
| 2026-06-24 | 55.47x |
| 2026-06-23 | 54.03x |
| 2026-06-22 | 54.65x |
| 2026-06-18 | 56.50x |
| 2026-06-17 | 53.83x |
| 2026-06-16 | 55.06x |
| 2026-06-15 | 56.92x |
| 2026-06-12 | 55.47x |
| 2026-06-11 | 55.06x |
| 2026-06-10 | 55.89x |
| 2026-06-09 | 56.71x |
| 2026-06-08 | 53.83x |
| 2026-06-05 | 55.47x |
| 2026-06-04 | 56.50x |
| 2026-06-03 | 55.27x |
| 2026-06-02 | 57.33x |
| 2026-06-01 | 58.77x |
| 2026-05-29 | 63.92x |
| 2026-05-28 | 63.51x |
| 2026-05-27 | 63.30x |
| 2026-05-26 | 63.92x |
| 2026-05-22 | 59.80x |
| 2026-05-21 | 62.48x |
| 2026-05-20 | 61.65x |
| 2026-05-19 | 60.01x |
| 2026-05-18 | 60.62x |
| 2026-05-15 | 59.59x |
| 2026-05-14 | 62.68x |
| 2026-05-13 | 61.86x |
| 2026-05-12 | 63.71x |
| 2026-05-11 | 66.39x |
| 2026-05-08 | 70.30x |
| 2026-05-07 | 70.72x |
| 2026-05-06 | 86.78x |
| 2026-05-05 | 83.69x |
| 2026-05-04 | 85.96x |
| 2026-05-01 | 84.31x |
| 2026-04-30 | 81.84x |
| 2026-04-29 | 82.46x |
| 2026-04-28 | 84.10x |
| 2026-04-27 | 86.57x |
| 2026-04-24 | 85.96x |
| 2026-04-23 | 81.84x |
| 2026-04-22 | 87.81x |
| 2026-04-21 | 82.04x |
| 2026-04-20 | 84.72x |
| 2026-04-17 | 84.10x |
| 2026-04-16 | 81.84x |
| 2026-04-15 | 82.04x |
| 2026-04-14 | 81.01x |
| 2026-04-13 | 79.37x |
| 2026-04-10 | 77.10x |
| 2026-04-09 | 76.69x |
| 2026-04-08 | 79.16x |
| 2026-04-07 | 76.48x |
| 2026-04-06 | 76.48x |
| 2026-04-02 | 74.63x |
| 2026-04-01 | 77.51x |
| 2026-03-31 | 23.50x |
| 2026-03-30 | 22.66x |
| 2026-03-27 | 22.15x |
| 2026-03-26 | 23.88x |
| 2026-03-25 | 24.20x |
| 2026-03-24 | 24.33x |
| 2026-03-23 | 25.41x |
| 2026-03-20 | 25.09x |
| 2026-03-19 | 25.61x |
| 2026-03-18 | 24.39x |
| 2026-03-17 | 25.80x |
| 2026-03-16 | 25.99x |
| 2026-03-13 | 25.86x |
| 2026-03-12 | 26.12x |
| 2026-03-11 | 26.56x |
| 2026-03-10 | 28.67x |
| 2026-03-09 | 27.97x |
| 2026-03-06 | 27.65x |
| 2026-03-05 | 27.91x |
| 2026-03-04 | 26.88x |
| 2026-03-03 | 26.44x |
| 2026-03-02 | 27.20x |
| 2026-02-27 | 27.59x |
| 2026-02-26 | 28.42x |
| 2026-02-25 | 29.38x |
| 2026-02-24 | 27.97x |
| 2026-02-23 | 27.33x |
| 2026-02-20 | 26.37x |
| 2026-02-19 | 26.88x |
| 2026-02-18 | 27.27x |
| 2026-02-17 | 28.93x |
| 2026-02-13 | 28.16x |
| 2026-02-12 | 27.84x |
| 2026-02-11 | 27.97x |
| 2026-02-10 | 28.03x |
| 2026-02-09 | 27.91x |
| 2026-02-06 | 28.55x |
| 2026-02-05 | 28.10x |
| 2026-02-04 | 30.72x |
| 2026-02-03 | 31.61x |
| 2026-02-02 | 34.23x |
| 2026-01-30 | 33.59x |
| 2026-01-29 | 33.59x |
| 2026-01-28 | 33.85x |
| 2026-01-27 | 35.19x |
| 2026-01-26 | 35.13x |
| 2026-01-23 | 33.72x |
| 2026-01-22 | 35.45x |
| 2026-01-21 | 34.94x |
| 2026-01-20 | 35.00x |
| 2026-01-16 | 34.87x |
| 2026-01-15 | 35.64x |
| 2026-01-14 | 35.64x |
| 2026-01-13 | 36.85x |
| 2026-01-12 | 36.15x |
| 2026-01-09 | 36.98x |
| 2026-01-08 | 37.24x |
| 2026-01-07 | 37.30x |
| 2026-01-06 | 38.52x |
| 2026-01-05 | 36.53x |
| 2026-01-02 | 35.26x |
| 2025-12-31 | 23.16x |
| 2025-12-30 | 23.65x |
| 2025-12-29 | 24.10x |
| 2025-12-26 | 24.31x |
| 2025-12-24 | 24.19x |
| 2025-12-23 | 23.78x |
| 2025-12-22 | 24.59x |
| 2025-12-19 | 23.82x |
| 2025-12-18 | 23.73x |
| 2025-12-17 | 22.87x |
| 2025-12-16 | 23.08x |
| 2025-12-15 | 23.20x |
| 2025-12-12 | 23.82x |
| 2025-12-11 | 24.27x |
| 2025-12-10 | 24.06x |
| 2025-12-09 | 23.78x |
| 2025-12-08 | 23.69x |
| 2025-12-05 | 23.53x |
| 2025-12-04 | 24.55x |
| 2025-12-03 | 23.86x |
| 2025-12-02 | 23.33x |
| 2025-12-01 | 24.43x |
| 2025-11-28 | 24.84x |
| 2025-11-26 | 25.33x |
| 2025-11-25 | 25.95x |
| 2025-11-24 | 25.21x |
| 2025-11-21 | 25.29x |
| 2025-11-20 | 24.59x |
| 2025-11-19 | 25.37x |
| 2025-11-18 | 25.21x |
| 2025-11-17 | 25.50x |
| 2025-11-14 | 25.25x |
| 2025-11-13 | 25.74x |
| 2025-11-12 | 26.52x |
| 2025-11-11 | 26.44x |
| 2025-11-10 | 26.19x |
| 2025-11-07 | 25.13x |
| 2025-11-06 | 24.14x |
| 2025-11-05 | 25.29x |
| 2025-11-04 | 25.58x |
| 2025-11-03 | 26.72x |
| 2025-10-31 | 27.99x |
| 2025-10-30 | 26.23x |
| 2025-10-29 | 26.89x |
| 2025-10-28 | 26.89x |
| 2025-10-27 | 28.24x |
| 2025-10-24 | 28.12x |
| 2025-10-23 | 27.50x |
| 2025-10-22 | 27.54x |
| 2025-10-21 | 27.87x |
| 2025-10-20 | 26.64x |
| 2025-10-17 | 27.13x |
| 2025-10-16 | 27.50x |
| 2025-10-15 | 27.83x |
| 2025-10-14 | 27.71x |
| 2025-10-13 | 27.67x |
| 2025-10-10 | 27.75x |
| 2025-10-09 | 28.08x |
| 2025-10-08 | 27.54x |
| 2025-10-07 | 26.52x |
| 2025-10-06 | 26.85x |
| 2025-10-03 | 25.50x |
| 2025-10-02 | 27.34x |
| 2025-10-01 | 29.43x |
| 2025-09-30 | 35.71x |
| 2025-09-29 | 38.06x |
| 2025-09-26 | 37.48x |
| 2025-09-25 | 36.04x |
| 2025-09-24 | 36.49x |
| 2025-09-23 | 39.30x |
Showing the most recent 260 of 818 data points. The chart above shows the full history.
